癌症患者谵妄:评估与管理

发布时间：2018-06-13 18:29

本文选题：癌症 + 谵妄　；参考：《医学与哲学(B)》2017年07期

【摘要】：谵妄是癌症患者最常见的一组神经精神综合征,并且与共病率和病死率密切相关。同时还会导致一系列负性结局,如医疗花费增加、住院时间延长、长期认知功能下降。对于谵妄早期评估、预防以及治疗近10年已经有了非常多的研究。本文就这一领域的新进展进行综述,表明在癌症患者中,研究证据多支持使用短期、低剂量抗精神病药控制谵妄症状。癌症患者谵妄的预防也得到更多的关注,特别是非药物干预对于存在谵妄或谵妄风险的癌症患者有着有益的作用。
[Abstract]:Delirium is the most common group of neuropsychiatric syndrome in cancer patients. It also leads to a series of negative outcomes, such as increased medical costs, prolonged hospital stay, and long-term cognitive decline. There has been a great deal of research on the early assessment, prevention and treatment of delirium in the past 10 years. A review of recent advances in this field suggests that in cancer patients, the evidence supports the use of short-term, low-dose antipsychotics to control delirium symptoms. More attention has also been paid to the prevention of delirium in cancer patients, especially non-drug intervention, which is beneficial to cancer patients at risk of delirium or delirium.
【作者单位】：北京大学肿瘤医院暨北京市肿瘤防治研究所康复科恶性肿瘤发病机制及转化研究教育部重点实验室;
【分类号】：R730.5

【相似文献】